1. |
Kimura H. Hydrogen sulfide as a neuromodulator [J]. Mol Neurobiol,2002, 26(1): 13-19.
|
2. |
康凱, 姜洪池.氣體信號分子硫化氫與疾病 [J]. 中國普外基礎與臨床雜志, 2009, 16(2): 170-173..
|
3. |
黃新莉, 周曉紅, 周君琳, 等.中性粒細胞在外源性硫化氫抗內毒素致急性肺損傷中的作用 [J]. 生理學報, 2009, 61(4):356-360..
|
4. |
Esechie A, Kiss L, Olah G, et al. Protective effect of Hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation [J]. Clin Sci, 2008, 115(3):91-97.
|
5. |
Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture [J]. Nat Protoc, 2009, 4(1): 31-36.
|
6. |
張學忠, 褚銀平, 孫彥龍, 等.靜脈使用不同劑量硫氫化鈉對正常大鼠機體的影響 [J]. 中西醫結合心腦血管病雜志,2009, 7(4): 452-454..
|
7. |
Collin M, Anuar FB, Murch O, et al. Inhibition of endogenous Hydrogen sulfide formation reduces the organ injury caused by endotoxemia [J]. Br J Pharmacol, 2005, 146(4): 498-505.
|
8. |
Isenmann R, Beger HG. Bacterial infection of pancreatic necrosis:role of bacterial translocation,impact of antibiotic treatment [J]. Pancreatology, 2001, 1(2): 79-89.
|
9. |
Turner JR. Intestinal mucosal barrier function in health and disease [J]. Nat Rev Immunol, 2009, 9(11):799-809.
|
10. |
李錕, 吳承堂, 張軍花, 等. 嚴重腹腔感染早期腸黏膜病理損害的實驗觀察 [J]. 南方醫科大學學報, 2006, 26(2): 202-204.
|
11. |
劉海燕, 李維勤, 黎介壽, 等.腹腔感染病人腸黏膜通透性的變化 [J]. 腸外與腸內營養,2008,15(6):332-334..
|
12. |
Ashton AK, Gurchumelidze T, Nazzal M, et al. Tumor necrosis Factor-α: a marker for peritoneal adhesion formation [J]. J Surg Res, 1995, 58(5): 516-518.
|
13. |
Pinget PF, Vesin C, Guo J, et al. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor and does not requier p53 [J]. Eur J Immunol, 1998, 28(11): 3499-3505.
|
14. |
Klebanoff SJ, Coombs RW. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1 [J]. J Clin Invest, 1992, 89(6): 2014-2017.
|
15. |
徐萍, 徐東升, 陳江, 等. 髓過氧化物酶對炎癥性腸病病情活動監測的臨床價值 [J]. 實用臨床醫學, 2006, 7(12): 34-37..
|
16. |
Rezende-Neto JB, Moore EE, Mαsuno T, et al. The abdominal compartment syndrome as a second insult during systemic neutrophil priming provokes multiple organ injury [J]. Shock, 2003,20(4): 303-308..
|
17. |
Noda T, Iwakiri R, Fujimoto K, et al. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa [J]. Am J Physiol, 1998, 274(2 Pt 1): G270-G276.
|
18. |
陳曉波, 杜軍保, 耿彬, 等.硫化氫對培養的大鼠主動脈平滑肌細胞增殖的抑制作用 [J]. 中國病理生理雜志, 2003, 19(8):1009-1011..
|
19. |
Liu H, Bai XB, Shi S, et al. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats [J]. J Pharm Pharmacol,2009, 61(2): 207-212.
|
20. |
Chen CQ, Xin H, Zhu YZ. Hydrogen sulfide:third gaseous transmitter, but with great pharmacological potential [J]. Acta Pharmacol Sin, 2007, 28(11): 1709-1716.
|
21. |
劉浩, 席孝忠, 程永剛, 等.硫化氫對多器官功能障礙綜合征大鼠的保護作用 [J]. 西安交通大學學報:醫學版, 2009,30(4): 482-485..
|
22. |
Eto K, Kimura H. Α novel enhancing mechanism for Hydrogen sulfide-producing activity of cystathionine beta-synthase [J]. Biol Chem, 2002, 277(45): 42680-42685.
|
23. |
Zhao WM, Joseph FN, Wang R. Modulation of endogenous product of H2S in rat tissues [J]. Physiol Pharmacol, 2003,81(9): 848-853.
|
24. |
Hu LF, Wong PT, Moore PK, et al. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia [J]. J Neurochem,2007, 100(4): 1121-1128.
|
25. |
Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse [J]. FASEB J, 2005, 19(9): 1196-1198.
|